標題: Titlebook: Oncologic Critical Care; Joseph L. Nates,Kristen J. Price Reference work 2020 Springer Nature Switzerland AG 2020 ICU.infectious diseases. [打印本頁] 作者: 喜悅 時間: 2025-3-21 18:00
書目名稱Oncologic Critical Care影響因子(影響力)
書目名稱Oncologic Critical Care影響因子(影響力)學科排名
書目名稱Oncologic Critical Care網(wǎng)絡公開度
書目名稱Oncologic Critical Care網(wǎng)絡公開度學科排名
書目名稱Oncologic Critical Care被引頻次
書目名稱Oncologic Critical Care被引頻次學科排名
書目名稱Oncologic Critical Care年度引用
書目名稱Oncologic Critical Care年度引用學科排名
書目名稱Oncologic Critical Care讀者反饋
書目名稱Oncologic Critical Care讀者反饋學科排名
作者: OASIS 時間: 2025-3-21 23:04
Considerations for Medications Commonly Utilized in the Oncology Population in the Intensive Care Unnt), metabolic complications, and diverse medication regimens with the potential for significant drug-drug interactions and overlapping adverse effects. This chapter will provide clinicians with an overview of non-chemotherapy medications frequently encountered in the critically ill oncologic patient, with a focus on practical considerations.作者: 聾子 時間: 2025-3-22 00:56 作者: anchor 時間: 2025-3-22 08:32
Complications and Toxicities Associated with Cancer Therapies in the Intensive Care Unite unit (ICU) admission to provide acute symptom management. Accordingly, ICU providers caring for cancer patients should have a working knowledge of the toxicities and complications associated with antineoplastic therapy.作者: Buttress 時間: 2025-3-22 12:48 作者: CHOP 時間: 2025-3-22 15:04
ield illustrations and photographs.Written by worldwide expeThis major reference work is the most comprehensive resource on oncologic critical care. The text reviews all significant aspects of oncologic ICU practices, with a particular focus on challenges encountered in the diagnosis and management 作者: 秘方藥 時間: 2025-3-22 20:33 作者: 鼓掌 時間: 2025-3-23 00:20 作者: 泛濫 時間: 2025-3-23 04:39 作者: 猛烈責罵 時間: 2025-3-23 08:38 作者: 消耗 時間: 2025-3-23 11:14
Reference work 2020agement, and palliative care.?.Written by worldwide experts in the field, .Oncologic Critical Care. is a valuable resource for intensivists, advance practice providers, nurses, and other healthcare providers, that will help close significant knowledge and educational gaps within the realm of medical care for critically ill cancer patients..作者: circuit 時間: 2025-3-23 16:38
Advanced Practice Providers in the Oncologic Intensive Care Unitzed processes ensuring that APPs have the necessary qualifications to provide direct safe patient clinical care. These processes will provide the highest level of reliability that the APP is providing safe competent care.作者: Rustproof 時間: 2025-3-23 18:34
Role of the Clinical Pharmacist in the Oncologic Intensive Care Unitlume of medication use. These practitioners should be familiar with the management of oncology-specific disease states and the complications associated with the treatment of malignancy. The integration of clinical pharmacists and clinical pharmacy services in oncology ICUs is imperative.作者: Abduct 時間: 2025-3-24 01:03
Antimicrobial Prophylaxis in High-Risk Oncology Patientscal site infections following procedures for the management of malignancy and for which postoperative admission to the intensive care unit may be necessary. The remainder of the chapter will highlight principles for the prevention of bacterial, fungal, and viral infections among the immunocompromised oncology population.作者: Opponent 時間: 2025-3-24 05:50 作者: 使出神 時間: 2025-3-24 09:28
ICU Utilizationtensive care unit (ICU) beds, utilization, and costs have continuously increased in general acute care hospitals in the United States over the past three decades. This chapter reviews and summarizes current literature related to ICU beds, utilization, and costs in general and oncologic critical care作者: 離開可分裂 時間: 2025-3-24 11:59
Critical Care Admissions and Discharge Criteria in Cancer Patientsnding of this group of patients, as well as the increasingly better and more targeted treatment options for their underlying disease, has led to a significant increase in their survival over the past two decades. We are living in an era in which we are defining the standards that offer the best way 作者: 胰島素 時間: 2025-3-24 18:01
ICU Staffing, Models, and Outcomes adequate staffing. The latter, considered one of the most challenging and controversial, is extensively discussed in this chapter. Optimal staffing of an ICU is highly dependent on multiple factors including, but not limited to availability of trained personnel, educational trainees, acuity of pati作者: invade 時間: 2025-3-24 23:04
Multidisciplinary Care of Critically Ill Cancer Patients advanced practice providers, nurses, clinical pharmacists, dieticians, physical therapists, occupational therapists, patient advocates, social workers, and chaplains are essential members of the multidisciplinary team working together to achieve a patient-centered approach when caring cancer patien作者: 報復 時間: 2025-3-25 02:30 作者: MAPLE 時間: 2025-3-25 05:09 作者: Esalate 時間: 2025-3-25 10:57
Rapid Response Team (RRT) in Critical Careand a Joint Commission’s national patient safety goal. The aim of implementing RTT in any organizations was to improve patient safety and quality of care through identifying deterioration in patient status and intervening to stabilize the patient in a timely manner. Members of the RRT include multid作者: 厚臉皮 時間: 2025-3-25 13:05
Quality Assurance and Improvement in the Intensive Care Unitives were made after the Institute of Medicine published the report: To Err Is Human, in 2000. Although innumerous quality and safety initiatives have been implemented and some improvements in health care delivery and outcomes have been demonstrated, gaps still exist. This chapter will describe meth作者: 鳴叫 時間: 2025-3-25 16:07
Patient Risk Prediction Models. This refusal was advocated by some critical care colleges who stated patients with metastatic cancers would be poor candidates for intensive care unit (ICU) admission. More contemporaneously, tremendous advances in antitumor therapies have evolved, and critically unwell cancer patients have demon作者: 龍蝦 時間: 2025-3-25 22:02 作者: Tidious 時間: 2025-3-26 02:38
Role of the Clinical Pharmacist in the Oncologic Intensive Care Unitmented in the primary literature, with positive outcomes in areas such as adverse drug events, drug-drug interactions, antimicrobial therapy, anticoagulant therapy, sedation/analgesia therapy, and provision of advanced cardiac life support. Recent research has shown that the presence of clinical pha作者: 凝視 時間: 2025-3-26 05:21 作者: jettison 時間: 2025-3-26 12:11 作者: GULF 時間: 2025-3-26 16:07
Considerations for Medications Commonly Utilized in the Oncology Population in the Intensive Care Uncer therapies due to improved survival rates. The management of these patients is complex due to immunosuppression (from the malignancy and/or treatment), metabolic complications, and diverse medication regimens with the potential for significant drug-drug interactions and overlapping adverse effect作者: Innovative 時間: 2025-3-26 17:14
Complications and Toxicities Associated with Cancer Therapies in the Intensive Care Unitmotherapy, including targeted therapies, immunotherapies, and cellular therapies. Currently, there are over 175 FDA-approved antineoplastic agents in the United States, many with a diverse and profound toxicity profile. Complications of antineoplastic therapy may result in the need for intensive car作者: 合同 時間: 2025-3-27 00:38 作者: investigate 時間: 2025-3-27 03:59 作者: echnic 時間: 2025-3-27 08:40 作者: PIZZA 時間: 2025-3-27 09:53
Early Warning Systems and Oncological Critical Care Unitsncancer-related comorbidities. Early identification of at-risk oncology patients would prove particularly beneficial to facilitate early and appropriate discussions for treatment goals, ceilings of care, and multidisciplinary team input. At present, generic early warning systems have not been valida作者: lacrimal-gland 時間: 2025-3-27 15:59
Rapid Response Team (RRT) in Critical Caream, in which responders to a specific situation are experts in related field. In the oncologic setting, the RRTs face unique challenges related to this patient population’s underlying malignancy, specified treatments and complications, as well as comorbidities.作者: Creditee 時間: 2025-3-27 19:47
Patient Risk Prediction Modelsupports frank and open communications with patients and their relatives. In the oncological population, there is a wealth of evidence to support the prognostic value of individual physiological derangements as superior outcome predictors to cancer stage or type. Despite this, general medical attitu作者: Needlework 時間: 2025-3-28 01:33
Outcomes in Critically Ill Oncologic Patientsival rates for patients with cancer who are admitted to the ICU have improved; therefore, admission should not be denied to patients only on the basis of their cancer diagnosis. Specialists who treat critically ill cancer patients should implement preventive measures to avoid in-hospital death of ca作者: BOOR 時間: 2025-3-28 05:59 作者: 粗語 時間: 2025-3-28 10:04
Anne Rain Tanner Brown,Michelle Horng,Terri Lynn Shigle作者: floaters 時間: 2025-3-28 11:11 作者: Gesture 時間: 2025-3-28 17:19
Anne M. Tucker,Jacob W. Hall,Christine A. Mowatt-Larssen,Todd W. Canada作者: Absenteeism 時間: 2025-3-28 19:25 作者: 淡紫色花 時間: 2025-3-29 01:23
https://doi.org/10.1007/978-3-319-74588-6ICU; infectious diseases; neurologic diseases; respiratory diseases; cardiovascular diseases; pain manage作者: 被告 時間: 2025-3-29 05:39 作者: 浮雕寶石 時間: 2025-3-29 10:41 作者: 勉強 時間: 2025-3-29 12:59
6樓作者: slow-wave-sleep 時間: 2025-3-29 16:55
6樓作者: 帽子 時間: 2025-3-29 22:57
7樓作者: 擔憂 時間: 2025-3-30 01:22
7樓作者: 喃喃而言 時間: 2025-3-30 06:26
7樓作者: nurture 時間: 2025-3-30 09:05
7樓作者: CT-angiography 時間: 2025-3-30 16:05
8樓作者: 館長 時間: 2025-3-30 19:34
8樓作者: Cocker 時間: 2025-3-30 20:52
8樓作者: 無思維能力 時間: 2025-3-31 01:08
8樓作者: 植物群 時間: 2025-3-31 07:41
9樓作者: Aura231 時間: 2025-3-31 12:10
9樓作者: jaundiced 時間: 2025-3-31 15:47
9樓作者: 慷慨不好 時間: 2025-3-31 20:30
9樓作者: cringe 時間: 2025-4-1 01:18
10樓作者: gain631 時間: 2025-4-1 02:16
10樓作者: 鬧劇 時間: 2025-4-1 07:36
10樓作者: 類型 時間: 2025-4-1 14:09
10樓
